Hanger (HNGR) Return on Assets ROA from the second quarter of 2022 to second quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket
 


Hanger inc.  (NYSE: HNGR)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Hanger's ROA from the second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Hanger's ROA in the second quarter of 2022?
Hanger inc. achieved a return on average assets (ROA) of 4.49 % in its second quarter of 2022, this is above HNGR's average return on assets of -6.18%.
Hanger Inc. assets over the 12 months ending in its second quarter of 2022 are valued at $831 million

ROA fell compared to the first quarter of 2022, despite the net income growth of % from the first quarter of 2022.

However, within the Healthcare sector 170 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2022 from 1764 to 1813.

What is ROA?



Return On Assets (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Total Assets Change 2.13 % 6.22 % -19.92 % -1 % 0.82 %
Y / Y Net Income Change -0.41 % - -12.66 % 209.86 % -67.29 %
Net Income (TTM) in million 37 37 42 44 30
Return On Assets (TTM) 4.49 % 4.51 % 5.15 % 5.07 % 3.41 %
HNGR's Total Ranking # 1813 # 1764 # 1841 # 1510 # 1773
Total Assets (TTM) in million 828 820 856 821 811
Seq. Total Assets Change 0.97 % -4.2 % 4.34 % 1.18 % 5.02 %
Seq. Net Income Change - - -33.53 % 107.86 % -



Return On Assets Company Ranking
Within: No.
Industry # 20
Sector # 171
Overall # 1782

Return On Assets Statistics
High Average Low
5.43 %
-6.18 %
-37.29 %
(Mar 31 2021)   (Sep 30 2016)





Financial Statements
Hanger's Assets $ 828 million HNGR's Balance sheet
Hanger's Income $ 10 million Quarterly HNGR's Income Statement
HNGR's Income by Division See HNGR's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
Y / Y Total Assets Change -19.92 % 26.94 % 19.81 % 9.77 % -15.19 %
Total Assets in million 856 1,069 842 703 640
Y / Y Net Income Change 9.92 % 38.75 % - - -
Net Income in million 42 38 28 -1 -105
Annual Return On Assets 4.9 % 3.57 % 3.27 % -0.12 % -16.34 %




Comment on HNGR's ROA in the fiscal year ending 2021
In the fiscal year 2021 ROA improved to 4.9 % compared to prior year, due to annual net income growth of 9.92 % to $41.98 million, and due to decline of value in Hanger's assets by -19.92 % to $856.21 million, compared to $856.21 a year before.


More Return On Assets Ratios
HNGR's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HNGR's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HNGR's Competitors
Subscribers only: Roa for Hanger's Suppliers
Subscribers only: Return On Assets for HNGR's Customers

You may also want to know
HNGR's Roi HNGR's Inventory Turnover Ratio HNGR's Growth Rates HNGR's Dividend Comparisons
HNGR's Profitability Ratios HNGR's Asset Turnover Ratio HNGR's Dividend Growth
HNGR's Roe HNGR's Valuation Ratios HNGR's Financial Strength Ratios HNGR's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2022, within Healthcare Sector ROA
Xoma Royalty Corporation  12.09 %
United Therapeutics Corporation  11.95 %
Eli Lilly And Company  11.92 %
Progyny Inc   11.60 %
Quest Diagnostics Inc  11.59 %
Bio techne Corp  11.53 %
Abbott Laboratories  11.51 %
Biofrontera Inc   10.99 %
Intuitive Surgical Inc   10.79 %
Amgen Inc   10.75 %
Align Technology inc   10.61 %
Docgo Inc   10.59 %
Carlisle Companies Incorporated  10.48 %
Organon and Co   10.24 %
Johnson and Johnson  10.24 %
Chemomab Therapeutics Ltd   9.94 %
Labcorp Holdings Inc   9.67 %
Staar Surgical Co  9.61 %
Meridian Bioscience Inc   9.41 %
Regenxbio Inc   9.32 %
Masimo Corp  8.95 %
3m Company  8.91 %
Atricure Inc   8.89 %
Fonar Corporation  8.87 %
Horizon Therapeutics Public Limited Company  8.77 %
Abbvie Inc   8.69 %
Pro dex Inc   8.54 %
Bruker Corporation  8.05 %
Henry Schein Inc   8.01 %
Globus Medical Inc   7.97 %


Date modified: 2026-09-18T13:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.